CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 304 enrolled
Drug / intervention
ERCPprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05920954
NCT05920954N/ACompleted

Urgent (<24 Hours) Versus Early (24 to 48 Hours) ERCP for Patients With Mild and Moderate Acute Cholangitis

Asian Institute of Gastroenterology, India·interventional·Posted Jun 27, 2023·Updated Oct 2, 2025

In Brief

A clinical study evaluating ERCP for Acute Cholangitis. Completed, enrolled 304 participants across 1 site.

Detailed Summary

Acute Cholangitis is an emergency associated with significant morbidity and mortality which require prompt recognition and treatment. The decompression of biliary tree along with antibiotics are mainstay of therapy. Randomized comparative studies showed that ERCP achieves biliary decompression with markedly less morbidity and mortality compared with surgery, regardless of clinical drainage. Percutaneous trans hepatic drainage (PTBD) can be alternative to endoscopic drainage in selected group especially advanced hilar strictures and patients who are unfit for endoscopic procedure. Recent ASGE guidelines suggested the performance of ERCP within 48 hours for patients with acute cholangitis; however it is conditional recommendation with very low quality of evidence. Till date, no randomized trial has compared urgent ERCP versus early ERCP for acute cholangitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesIndia
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedJun 27, 2023
Enrollment StartJun 30, 2023
Primary CompletionJun 10, 2024
Study CompletionJul 10, 2024
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 3.0 years ago

Interventions

ERCPprocedure

Repeat ERCP